INTRODUCTION
The neuronal calcium sensor (NCS) protein family consists of a group of Ca 2+ -binding proteins whose expression is restricted to neuronal systems including retinal photoreceptor cells (Burgoyne and Weiss, 2001; Haeseleer et al., 2002; Palczewski et al., 2000; Polans et al., 1996) . These proteins bind Ca 2+ through EF-hand motifs and many of them are fatty acylated at the amino terminus, most frequently with myristic acid (Ames and Ikura, 2002) . NCS proteins serve as switches for Ca 2+ signaling by assuming different conformations upon Ca 2+ binding and dissociation. Two members of this family, recoverin and guanylate cyclase-activating proteins (GCAPs), play roles in phototransduction, whereas other family members mediate diverse Ca 2+ -dependent neuronal processes such as neurotransmitter release, modulation of ion channels, and regulation of gene expression (Burgoyne, 2007) . Despite their sequence similarity, NCS proteins possess specialized activities and are typically not interchangeable (Burgoyne, 2007) .
Phototransduction in retinal photoreceptors is modulated by Ca 2+ signaling (Palczewski et al., 2000; Polans et al., 1996) . Photon absorption by opsins triggers a signaling cascade that results in hydrolysis of the second messenger cGMP in the cytoplasm. As cellular cGMP levels drop, cGMP-gated cation channels close and photoreceptor cells hyperpolarize, leading to synaptic transmission of the light signal. Reconstitution of the dark potential requires activation of photoreceptor guanylate cyclases (GCs) to replenish the cGMP pool. This process is Ca 2+ dependent and mediated by GCAPs. Closing of the cGMP-gated cation channels occurs and Ca 2+ is extruded from the cytoplasm by the Na + /Ca 2+ -K + exchanger, which lowers free Ca 2+ from a dark concentration of $500 nM, to $30 nM. Whereas Ca 2+ -bound GCAPs inhibit photoreceptor GCs, a drop in free Ca 2+ results in GCAPs losing their bound Ca 2+ and adopting a conformation that activates photoreceptor GCs and restores the pool of cGMP (Polans et al., 1996) . Two GCAPs (GCAP1 and GCAP2) first isolated from bovine retina (Dizhoor et al., 1995; Gorczyca et al., 1995; Palczewski et al., 1994) are present in all mammals. A third isoform, GCAP3, is expressed in human and zebrafish (Danio rerio) retinas (Haeseleer et al., 1999; Imanishi et al., 2002) , and a guanylate cyclase-inhibitory protein (GCIP) has been identified in frog cones . At least five additional GCAPs (GCAP4-8) are predicted to be present in pufferfish (Fugu rubripes) and zebrafish genomes (Imanishi et al., 2004) . These are all amino-terminal acylated proteins with four EF-hand motifs, one of which, EF-1, is unable to bind Ca 2+ . In vitro and in vivo, GCAP1 and GCAP2 regulate both photoreceptor GCs (GC1 and GC2, also known as GC-E and GC-F) (Baehr et al., 2007) . However, GCAP1 and GCAP3 are primarily expressed in cones, whereas GCAP2 is prevalent in rods (reviewed in Dizhoor and Hurley, 1999; Haeseleer et al., 2002) . Autosomal dominant cone dystrophies have been associated with single point mutations in human GCAP1 , but no disease-causing mutations have been identified in either GCAP2 or GCAP3. Specifically, Y99C, I143NT, L151F, and E155G mutations in GCAP1 have been linked to autosomal dominant cone dystrophies (for the most recent report, see Sokal et al., 2005) . Each of these mutations leads to altered Ca 2+ sensitivity of GCAP1, resulting in incomplete inhibition of GC1 at high Ca 2+ concentrations, an abnormally high cGMP concentration in cone cells, and retinal degeneration. Another mutation, P50L, appears to lower the stability of GCAP1 in association with cone apoptosis (Newbold et al., 2002) . Whereas E155G clearly disables Ca 2+ binding to EF-4 by removing one of the key Ca 2+ -coordinating side chains, the molecular mechanisms for the other disabling mutations are less certain.
Recoverin is probably the best structurally characterized protein among the myristoylated NCS (myrNCS) family. NMR structures of myristoylated recoverin (myr-recoverin) in the Ca 2+ -bound and Ca 2+ -free states illustrate its Ca 2+ -triggered conformational changes (Ames et al., 1997) . The Ca 2+ -free form of myr-recoverin sequesters the acyl group in a hydrophobic cleft of its N terminus, rendering the protein soluble in the cytosol. Upon Ca 2+ binding, the myristoyl group is extruded and becomes fully exposed. This process is known as the ''calcium-myristoyl switch'' and allows the recruitment of myr-recoverin to membranes upon Ca 2+ binding (Valentine et al., 2003) .
Other myrNCS proteins including hippocalcin and neurocalcin also function by a similar mechanism (Burgoyne and Weiss, 2001; O'Callaghan et al., 2002; Spilker et al., 2000) . However, some myrNCS proteins such as NCS-1 and GCAPs do not appear to undergo a canonical calcium-myristoyl switch (Hwang and Koch, 2002; Olshevskaya et al., 1997) . Whereas membrane localization of GCAPs does not depend on Ca 2+ concentration (Gorczyca et al., 1995) , GCAP1 myristoylation is required for appropriate regulation of GC1 within the physiological Ca 2+ concentration range (Hwang and Koch, 2002; Otto-Bruc et al., 1997) . Thus, the role of the myristoyl group in GCAPs has been unclear. Here we present the 2.0 Å resolution crystal structure of myrGCAP1 with Ca 2+ bound, to our knowledge the first crystallographic example of a myrNCS. We show that, in contrast to recoverin and contrary to earlier reports, the myristoyl group is completely buried in the Ca 2+ -bound state of myrGCAP1. The protein adopts a structure that buries the acyl group between the N-and C-terminal helices, which harbor sequences previously identified as crucial for GCAP1 regulation of photoreceptor GCs. Moreover, we provide direct evidence for the nonswitching nature of the myristoyl group in GCAPs by showing that the acyl group remains buried inside the protein upon Ca 2+ dissociation from myrGCAP1. We also present a plausible molecular mechanism for the effect of the Y99C mutation in human GCAP1 that is associated with cone dystrophies.
RESULTS

MyrGCAP1 Structure Overview
We have determined the crystal structure of chicken myristoylated GCAP1 (myrGCAP1) with Ca 2+ bound and refined it to 2.0 Å resolution (refinement statistics are shown in Table 1 ). The protein carries a G6S mutation to increase the efficiency of myristoylation by a coexpressed yeast N-myristoyl transferase. Efficient GCAP1 myristoylation was confirmed by mass spectrometry and the purified protein was fully active in regulating photoreceptor GC (data not shown). The final model contains all but the C-terminal 14 amino acids that could not be traced, presumably as a result of conformational flexibility. These residues are not required for GCAP1 activity, as previously shown by C-terminal truncation of GCAP1 (Otto-Bruc et al., 1997) . Importantly, very clear electron density allowed the unambiguous modeling of the amino-terminal myristoyl group in the myrGCAP1 structure. Our structure of Ca
2+
-bound myrGCAP1 captures this protein in the form that inhibits GC. Failure of GCAP1 to fully inhibit GC1 at high Ca 2+ concentration is associated with cone degeneration Sokal et al., 1998) . The four EF-hand motifs are arranged in two domains in Ca
-bound myrGCAP1 (Figure 1 ). EF-1 (residues 17-42) and EF-2 (residues 50-82) form the Nterminal domain, whereas EF-3 (residues 87-118) and EF-4 (residues 130-160) are contained in the C-terminal domain. A short loop between EF-2 and EF-3 links these domains together. Ca 2+ ions are bound to EF-2, EF-3, and EF-4, whereas EF-1 does not bind Ca
, as observed for other GCAPs (Ames et al., 1999; Stephen et al., 2006) . As a consequence, the interhelical angle between the two helices of EF-1 is 125
, significantly larger than the average 108 observed for the Ca 2+ -occupied EF-2-4.
The overall structure of myrGCAP1 is quite compact. The link between the N-and C-terminal domains in myrG-CAP1 is strengthened by a novel interaction between the N-and C-terminal helices. The C-terminal helix (green in Figure 1 ) is partially unraveled and sharply kinked, and it interacts in an antiparallel orientation with the N-terminal helix (red in Figure 1 ) tying the two domains together.
The Myristoyl Group Is Completely Buried in
The present structure of Ca
2+
-bound myrGCAP1 is, to our knowledge, the first example of a myristoylated GCAP and the fatty acid is unambiguously observed in the electron density map (Figure 2A ). In sharp contrast to Ca 2+ -bound recoverin (see below), the myristoyl group in Ca 2+ -bound GCAP1 is completely buried in the core of the N-terminal domain (Figure 1 ).
Both EF hands from the N-terminal domain contribute hydrophobic side chains to form the binding pocket for the myristoyl group (Figures 1 and 2B ). Residues W20, F38, and F42 are from EF-1 (the non-Ca 2+ -binding EF), whereas the Ca 2+ -bound EF-2 supplies residues V55, M58, F62, Y75, L79, and V82. The N-and C-terminal helices play a crucial role in binding the myristoyl group. The N-terminal helix contributes residues M4, V9, and L12. Importantly, the C-terminal portion of the kinked C-terminal helix (green in Figures 1 and 2 ) forms one side of the myristoyl-binding pocket, contributing the side chains of residues L174, I177, V178, and I181. These interactions further strengthen the structural link between the N-and C-terminal domains of GCAP1.
GCAP1 is acylated at the N terminus in vivo (primarily with myristic acid) (Palczewski et al., 1994) and acylation is required for efficient regulation of photoreceptor GCs within the physiological range of Ca 2+ concentrations.
However, unmyristoylated GCAP1 (unmyrGCAP1) can regulate GC1 in vitro, albeit with reduced efficiency and altered Ca 2+ sensitivity (Hwang and Koch, 2002; Otto-Bruc et al., 1997) . This result suggests that unmyrGCAP1 is at least partially folded. We obtained far-UV circular dichroism (CD) spectra of myristoylated and unmyristoylated 
, where I i (h) is the Ith measurement of reflection h and < I(h) > is the weighted mean of all measurements of h. Bijvoet measurements were treated independently for the MAD phasing data sets.
, where F H is the structure factor amplitude for anomalous scatterers and 3 is the lack of closure expression for each wavelength in the MAD data set. d FOM before DM indicates the figure of merit before density modification. e R work = P jF obs À F calc j/ P F obs , where F obs = observed structure factor amplitude and F calc = structure factor calculated from the model. R free is computed in the same manner as R cryst , using the test set of reflections.
GCAP1 at 25
C to evaluate the secondary structure of these two forms of GCAP1 in the presence of Ca 2+ (see Figure S1 in the Supplemental Data available with this article online). As expected, no massive changes in overall secondary structure content are observed. However, there is some loss of ellipticity in the unmyristoylated protein. This change is probably a result of unraveling of the N-and C-terminal helices when the myristoyl group is not present to constrain their conformations, consistent with increased proteolytic accessibility reported previously (Rudnicka-Nawrot et al., 1998) . It is worth noting that Ca 2+ -saturated unmyrGCAP1 failed to crystallize despite extensive trials. This observation also is consistent with the increased conformational flexibility in GCAP1 when the myristoyl group is absent.
Acyl Packing in MyrGCAP1 and Myr-Recoverin
The packing of the myristoyl group in our structure of Ca 2+ -bound myrGCAP1 is opposite that observed for the acyl group in Ca 2+ -bound recoverin ( Figures 3A-3C ). The NMR structure of myr-recoverin shows complete exposure of the acyl group in the Ca 2+ -bound state (Ames et al., 1995 (Ames et al., , 1997 , whereas the myristoyl group in Ca 2+ -bound myrG-CAP1 is completely buried inside the protein (Figure 1 ). In recoverin, transition to its Ca 2+ -free conformation is accompanied by sequestration of the acyl group in a hydrophobic cleft of its N-terminal domain that characterizes the so-called calcium-myristoyl switch (Ames et al., 1997) . Thus, both myr-recoverin and myrGCAP1 are able to bind the acyl group in a solvent-inaccessible site. However, superposition of the N-terminal domains of Ca 2+ -bound GCAP1 and Ca 2+ -free recoverin shows that these proteins sequester the acyl group in very different orientations. As shown in Figures 3D-3F , the structures of the two proteins diverge at the entering helix to EF-1 (orange rod for GCAP1, yellow rod for recoverin) that fails to bind Ca 2+ in both proteins. The loop (red rod for GCAP1, light-red rod for recoverin) connecting this EF-1 helix to the N-terminal helix (magenta rod for GCAP1, light-pink rod for recoverin) is much shorter in GCAP1 than it is in recoverin. As a consequence, the N-terminal helices pack against the N-terminal domains of GCAP1 and recoverin in opposite directions so that the binding orientations for the buried myristoyl groups are almost perpendicular to one another. Thus, although a few conserved hydrophobic residues participate in acyl binding in both myrGCAP1 and myr-recoverin, the acyl orientation and binding sites diverge between these two proteins.
MyrGCAP1 Does Not Undergo a Ca
2+
-Induced Myristoyl Switch We tested whether solvent exposure of the acyl group changes in the Ca 2+ -free state of GCAP1 with an in vitro fluorescence-quenching assay. We replaced the myristoyl group of GCAP1 with a fluorescently labeled fatty acid (16-nitrobenzoxadiazole [NBD]-palmitoyl) using an in vitro acylation system (Towler et al., 1987) and then monitored solvent exposure of the acyl group by fluorescencequenching methodology. Figure 4 shows that low millimolar concentrations of Cs + efficiently quench the fluorescence emission of free 16-NBD-palmitoyl-CoA. In contrast, the fluorescent acyl group is largely inaccessible to the quencher when it is attached to Ca 2+ -saturated 16-NBD-palmitoyl-GCAP1, consistent with the buried acyl group observed in the crystal structure. Moreover, the fluorescent acyl group attached to GCAP1 remained inaccessible to the quencher when the protein was incubated in EGTA to induce its Ca
-free conformation ( Figure 4A ). Similar results were observed using I À anion and acrylamide as quenchers (data not shown). Thus, these observations indicate that the N-terminal acyl group in GCAP1 remains buried inside the protein in both the Ca 2+ -bound and Ca 2+ -free states. Furthermore, NBD fluorescence shifted toward shorter wavelengths (from 532 nm for free NBD to 526 nm for NBD-GCAP) when the fluorophore was attached to the protein, thereby indicating a more hydrophobic environment for the probe ( Figure 4B ). Thus, GCAP1 has a nonswitchable myristoyl group that remains buried inside the protein in both the Ca
-bound and Ca
-free states.
Stabilization of the Kink in the C-Terminal Helix
The C-terminal stretch of polypeptide containing amino acids 162-184 (shown in green in the figures) adopts a helical conformation where the central residues (170-174) are partially unraveled, thereby introducing a sharp kink in the helix. This kink is required for the most C-terminal part of that helix to contact the N-terminal helix (red in Figure 1 ) and the myristoyl group, creating a strong bridge between the N-and C-terminal domains of GCAP1 (Figures 1A and 1B). As described below, residue Y98 is involved in stabilizing the C-terminal helix kink. Importantly, mutation of this Tyr to Cys in human GCAP1 (Y99C with human protein numbering) renders the protein unable to fully inhibit GC at a physiologically high freeCa 2+ concentration ($0.5 mM), which in turn leads to cone degeneration and retinal disease . Thus, stabilization of the C-terminal helix kink appears crucial for the physiological role of GCAP1. A network of hydrogen-bonding interactions between the main-chain atoms of the C-terminal helix and the surrounding side chains stabilizes the kinked helix conformation ( Figure 5A ). In ideal a helices, the carbonyl groups of peptide bonds are aligned with the helix axis. In this orientation, the carbonyl from a residue at position n hydrogen bonds with the amide nitrogen of the residue at position n + 4. The C-terminal helix of GCAP1 is first unraveled by stabilizing the carbonyl of L168 (residue n) out of alignment with the helix axis through a hydrogen bond with the side chain of Y98. The amide nitrogen of L172 (the n + 4 residue) is then hydrogen bonded to the side chain of Y94. Partial unraveling of the helix is further stabilized by hydrogen-bonding interactions between the main-chain carbonyl of S171 with the side chain of R123. The kinked conformation is stabilized by a hydrogen bond between the main-chain carbonyl of R170 and the imidazole nitrogen of H176, as well as a salt bridge between the side chains of R170 and E162.
Residue Y98 plays an important role in the stabilization of the C-terminal helix kink. Y98 is located at the boundary between the entering helix and the Ca 2+ -binding loop of EF-3, and its aromatic ring is tightly packed ( Figure 5B ). Moreover, it is sandwiched between two layers of hydrophobic residues with I118, Y94, L97, and I114 on one side and I115, L111, L168, F154, and I106 on the other. Water molecules appear to be excluded from this site, as no crystallographic water molecules are visible within 9 Å of the Y98 aromatic ring. Hydrophobic interactions around Y98 are also linked to the Ca 2+ -bound conformation of EF-3 ( Figure 5B ). In a typical EF-hand motif, loop residues in positions 1, 3, 5, 7, 9, and 12 directly coordinate the Ca 2+ ion. Significantly, I106 (one of the hydrophobic residues that interact with Y98) occupies position 8 in the Ca 2+ -binding loop in EF-3. A Y98C mutation, associated with retinal disease in humans , would destabilize the C-terminal helix kink in two ways, by (1) abolishing the hydrogen bond between Y98 and the carbonyl oxygen of L168 (the first residue in the helix kink), and (2) creating a void volume in the hydrophobic core of the protein as a result of the much smaller size of the Cys residue side chain compared to Tyr.
Structural Comparison of MyrGCAP1 and Unacylated GCAPs
Comparisons between the Ca 2+ -bound structures of myr-GCAP1 and unmyristoylated GCAP2 (unmyr-GCAP2; Figure 6A ) and unmyristoylated GCAP3 (unmyr-GCAP3; Figure 6B ) highlight the role of the myristoyl group in stabilizing the GCAP1 structure. Although the overall architecture and conformation of the Ca 2+ -binding EF hands are conserved between the myristoylated and unmyristoylated proteins, the structure of the N-and C-terminal helices is severely affected in the unmyristoylated proteins. (A) The kink in the C-terminal helix and the side chains important for its stabilization are shown as sticks. The color scheme is as in Figure 1 and hydrogen bonds are shown as red dotted lines. (B) Packing of Y98 (whose mutation to C98 is linked to retinal disease) among hydrophobic side chains (shown as sticks) between EF-3 and the kink of the C-terminal helix (in green sticks).
In the absence of the acyl group, the C-terminal portion of the kinked C-terminal helix is severely destabilized in the NMR structure of unmyrGCAP2 to the extent that no nuclear Overhauser effect (NOE) peaks could be assigned for this region, thus preventing its modeling (Ames et al., 1999 ) (represented as a cyan dashed line in Figures 6A and 6C) . Additionally, the N-terminal region of unmyrGCAP2 displays a significant degree of conformational flexibility in the NMR structure (Ames et al., 1999) , and the N-terminal helix (magenta in Figures 6A and 6C ) is in a conformation that would prevent myristoyl binding as seen in myrGCAP1. It is possible that myrGCAP2 packs its acyl group in a way that differs from myrGCAP1. It seems more likely, however, that the conformation of the N-terminal helix observed in the structure of unmyrGCAP2 results from not having the packing constraints imposed by the N-terminal acyl group buried in a binding site similar to GCAP1. In this context, it is notable that the hydrophobic residues lining the myristoyl-binding site in GCAP1 are conserved in all GCAPs (Imanishi et al., 2004) .
Similar conformational instability of the N-and C-terminal helices was observed in the crystal structure of unmyrG-CAP3 as evidenced by its superimposition with myrGCAP1 ( Figure 6B ). The N-terminal helix in unmyrGCAP3 is extremely flexible, to the point that it could not be modeled in the crystal structure (Stephen et al., 2006 ) (shown as a magenta dashed line in Figures 6B and 6E ). Even the entering helix of EF-1 is poorly defined in the crystal structure of unmyrGCAP3. In addition, the C-terminal portion of the kinked C-terminal helix (cyan in Figures 6B and 6E) is packed against the N-terminal domain in unmyrGCAP3 in a fashion that would prevent myristoyl binding as seen in myrGCAP1. Again, the flexibility and conformation of the N-and C-terminal helices in unmyrGCAP3 are likely a result of the absence of the stabilizing acyl group.
Therefore, the N-terminal acylation of GCAPs observed physiologically is important to maintaining the structural integrity of their N-and C-terminal helices. This proposal is consistent with the observation that unmyristoylated GCAPs regulate photoreceptor GCs in vitro with reduced efficiency and altered Ca 2+ sensitivity (Hwang and Koch, 2002; Otto-Bruc et al., 1997).
DISCUSSION
GCAPs are members of the NCS protein family of which recoverin, also myristoylated at the N terminus, is probably the best structurally characterized (Palczewski et al., 2000) . -bound state, the acyl group would be exposed in myrGCAP1. This assumption was supported by 1 H-NMR studies suggesting exposure of the acyl group in myrGCAP2 (Hughes et al., 1998) . However, our crystal structure demonstrates that, in contrast to recoverin, the myristoyl group is completely buried in the interior of the N-terminal domain of Ca 2+ -bound myrGCAP1. We also used a direct assay to test the solvent exposure of the acyl group of GCAP1 in solution. Consistent with the structure, when the myristoyl group was replaced with a fluorescent acyl group, the fluorophore was inaccessible to quenching cesium ions (and other quenchers) and displayed emission maxima indicative of a hydrophobic environment. Importantly, the fluorophore remained inaccessible to the solvent and displayed similar spectral features when the protein was incubated with EGTA to induce its Ca 2+ -free state. This result indicates that, in contrast to recoverin, the myristoyl group in GCAP1 is not subject to Ca 2+ -induced switching. The nonswitching nature of the acyl group was suggested previously for myrGCAP2 based on a few chemical shift changes in the myristoyl 1 H-NMR spectra of the Ca 2+ -bound and Ca 2+ -free forms of this protein (Hughes et al., 1998) . Our crystal structure of Ca
2+
-bound myrGCAP1 does not show solvation of the myristoyl group. Instead, the structural and fluorescence data indicate that the acyl group remains buried inside GCAP1 at all physiological concentrations of free Ca 2+ . Furthermore, previous studies of GCAP membrane association also indicated the absence of a canonical, recoverin-like myristoyl switch in GCAPs (Hwang and Koch, 2002; Olshevskaya et al., 1997) . GCAPs are not recruited to membranes in response to changes in Ca 2+ concentration, but rather remain membrane associated at all Ca 2+ concentrations (Gorczyca et al., 1995; Olshevskaya et al., 1997) . Moreover, surface plasmon resonance data showing no Ca 2+ dependence of the association of GCAPs to immobilized phospholipid membranes also agree with a nonswitchable model for myrGCAP1 (Hwang and Koch, 2002) . The NCS family has expanded during evolution such that five classes (A-E) of NCS proteins have been defined based on amino acid sequence . NCS-1, also known as frequenin, represents class A NCS proteins and is the earliest evolutionary member of the NCS family with an ortholog present in yeast . NCS-1 is myristoylated at the N terminus and associated with membranes, but its membrane association is not Ca 2+ dependent so NCS-1 is thought to lack a Ca 2+ -myristoyl switch. Although no structure of myristoylated NCS-1 is yet available, 1 H-NMR studies suggest that its myristoyl group is solvent exposed at all Ca 2+ concentrations, consistent with its invariant membrane association . This led to the suggestion that the capability to sequester the acyl group inside the protein was acquired later in evolution (O'Callaghan and . Class B NCS proteins that include hippocalcin, neurocalcin, and visinin-like proteins have orthologs in nematodes and constitute the earliest evolutionary example of proteins that undergo a recoverin-like Ca 2+ -myristoyl switch. Recoverin and class B NCS proteins such as neurocalcin share similar structures (VijayKumar and Kumar, 1999), high overall sequence similarity ($55% for bovine proteins), and conservation of the hydrophobic residues responsible for myristoyl binding (Vijay-Kumar and Kumar, 1999) . Therefore, class B NCS proteins are thought to have recoverin-like, myristoylbinding pockets (Vijay-Kumar and Kumar, 1999) . On the other hand, GCAPs which make up class D NCS proteins first identified in fish genomes have diverged in how the myristoyl group is bound and how they respond to Ca 2+ binding and dissociation. Together, these observations suggest that GCAPs with a nonswitching, permanently buried myristoyl group were the most recent of the myrNCS proteins to evolve.
Our structure of Ca 2+ -bound myrGCAP1 captures the protein in the form responsible for inhibiting GC. Incomplete inhibition of photoreceptor GCs within physiological free-Ca 2+ concentrations leads to increased cellular levels of cGMP and results in retinal disease. Amino-terminal acylation of GCAP1 is required for full activity at physiological concentrations of Ca 2+ (Hwang and Koch, 2002; OttoBruc et al., 1997) . The GCAP1 structure shows that the myristoyl group is a central feature in the hydrophobic core of the N-terminal domain that, by contacting the Cterminal portion of the kinked C-terminal helix, helps solidify the bridge between the N-and C-terminal domains of GCAP1. In contrast, structures of unmyristoylated GCAP2 and GCAP3 display conformational instability of their N-and C-terminal helices. Although no structure of unmyristoylated GCAP1 is yet available, CD data also are consistent with the structural instability of the N-and C-terminal helices in unmyristoylated GCAPs. The presence of the myristoyl group and the partial unraveling and kink of the C-terminal helix allow clustering of the N-terminal helix and C-terminal residues 175-183, previously identified as crucial for GCAP1 activity (Krylov et al., 1999; Li et al., 2001; Otto-Bruc et al., 1997; Palczewski et al., 1994; Schrem et al., 1999) . GCAP1 is partially inactivated by deletion of its first 10 amino acids and completely inactivated when missing the first 25 residues (Otto-Bruc et al., 1997) that remove the N-terminal helix and part of the entering helix of EF-1. Similarly, peptide inhibition studies have shown that myristoylated N-terminal peptides of GCAP1 can inhibit myrGCAP1-stimulated photoreceptor GC activity (Palczewski et al., 1994; Schrem et al., 1999) . Frog retinae have GCIP, which is closely related to GCAP1 and can only inhibit photoreceptor GCs. Replacing the first 20 amino acids of GCAP1 with the corresponding residues from GCIP resulted in a chimera unable to activate photoreceptor GCs at low concentrations of free Ca 2+ . Conversely, replacing the first 55 residues of GCIP with residues 1-46 from GCAP1 produced a chimera that activated photoreceptor GCs at low concentrations of Ca 2+ and inhibited photoreceptor GCs at high free-Ca 2+ concentrations (Li et al., 2001 ). Therefore, the N-terminal region of GCAP1 is crucial for stimulation of photoreceptor GCs at low free concentrations of Ca 2+ . Similarly, chimeras prepared between GCAP1 and recoverin also identified residues 21-27 in the N-terminal region of GCAP1 as crucial for activation of photoreceptor GCs, whereas the first 9 residues were also required for inhibition (Krylov et al., 1999) . The kinked C-terminal helix observed in the GCAP1 structure is also crucial for its activity. Previous work has shown that C-terminal deletions of the kinked helix (amino acids 159 through the end) are unable to activate photoreceptor GCs at low concentrations of free Ca 2+ (Krylov et al., 1999) . C-terminal truncations ending in amino acids 172 or 176 also result in proteins unable to activate GC. In fact, these truncations suppress photoreceptor GC activity at low concentrations of Ca
. Furthermore, a chimera where the C-terminal helix of GCAP1 was replaced with the C-terminal region of recoverin was unable to activate photoreceptor GCs at low concentrations of Ca 2+ , indicating that the specific sequence encompassing amino acids 157-182 in GCAP1 is required for photoreceptor GC activation (Krylov et al., 1999) . The most important residues in this region were further delimited to the stretch of polypeptide from R178 through R182. Importantly, the latter represents the most C-terminal half of the kinked C-terminal helix that packs against the N-terminal helix and myristoyl group in this structure.
We were unable to model the last 14 residues of GCAP1. However, a truncation that eliminates these amino acids (residues 183 through the end) from bovine GCAP1 did not significantly affect its ability to regulate photoreceptor GCs (Krylov et al., 1999) . Therefore, the crystallographic model presented here contains all the regions of GCAP1 important for activity and shows them clustering together around the myristoyl group.
The partial unraveling and kink in the C-terminal helix is crucial for packing together the N-and C-terminal regions important for activity. Secondary structure prediction programs consistently assign residues 162-182 to a continuous helix. However, this stretch of polypeptide is partially unraveled and kinked in the middle in myrGCAP1. This feature is also observable in the structures of unmyristoylated GCAP2 and GCAP3. A network of hydrogen bonds and hydrophobic interactions stabilizes the conformation of this helix. This structure is required to allow the most C-terminal portion to contact the N-terminal helix and the myristoyl group, thereby forming a cluster of residues important for activity. Mutations altering this kink stabilization network may affect the position of the most C-terminal portion of the C-terminal helix and thus impact GCAP1 activity. We propose that the Y99C mutation in human GCAP1 (Y98 in this structure of chicken GCAP1) destabilizes the C-terminal helix kink and results in incomplete inhibition of photoreceptor GCs at high physiological concentrations of Ca 2+ , causing retinal disease. The N-and C-terminal helices of GCAP1 are important for activation or inhibition of photoreceptor GCs in a Ca 2+ -dependent manner. The clustering of these helices and the myristoyl group observed in the structure of Ca 2+ -bound GCAP1 may be responsible for GCAP1 inhibition of photoreceptor GCs at high concentrations of Ca 2+ . It is tempting to speculate that a transition to the Ca 2+ -free state of GCAP1 might pull these two helices apart, yielding the conformation responsible for photoreceptor GC activation at low concentrations of Ca
. A change in the relative orientation between the N-and C-terminal domains as seen upon Ca 2+ dissociation in recoverin would indeed pull the N-and C-terminal helices apart in Ca 2+ -free GCAP1. Moreover, mutations destabilizing the kink in the C-terminal helix also would enhance dissociation of the N-and C-terminal helices, thereby favoring photoreceptor GC activation. This is the effect of the Y99C mutation in human GCAP1. Critical support for this hypothesis of photoreceptor GC regulation by GCAP1 awaits elucidation of the structure of Ca 2+ -free GCAP1 and its complexes with GC.
EXPERIMENTAL PROCEDURES Protein Expression and Purification
See the Supplemental Experimental Procedures.
Crystallization and Structure Determination
Initial crystallization screening for chicken myrGCAP1 was carried out using TOPAZ 1.96 microfluidic crystallization chips (Fluidigm). Diffraction-quality crystals were then grown using the hanging-drop vapordiffusion method at 16 C (protein/precipitant, 1.5 ml/1.5 ml).Well-diffracting crystals were obtained from 0.1 M MES (pH 6.5), 24% PEG 20,000, and 0.4 M KNO 3 , using a myrGCAP1 protein stock supplemented with 6 mM BaCl 2 . The crystals were adapted to a cryoprotecting solution consisting of mother liquor and 25% ethylene glycol and then flash-frozen in a nitrogen stream at 100K. A data set to 2.0 Å resolution was collected from these crystals at beamline 8.2.2 of the Advanced Light Source (ALS). The crystals belong to space group P4 1 2 1 2 and contain one molecule per asymmetric unit with cell dimensions provided in Table 1 . Although Ba 2+ was present in the crystallization mix, no peaks were observed in the anomalous difference Patterson map and therefore could not be used for phasing. Thus, these crystals are regarded as ''native.'' Crystals grown in 0.1 M Tris-Cl (pH 8.0) containing 1.8 M ammonium sulfate were soaked for 4 hr in mother liquor containing 10 mM YbCl 3 . The soaked crystals were cryoprotected and flash-frozen as described above. Their structure was determined by multiwavelength anomalous dispersion (MAD) techniques using a three-wavelength data set to 3.4 Å resolution collected at beamline 8.3.1 of the ALS. These crystals also belong to space group P4 1 2 1 2 and are isomorphous with the native crystals described above. Three clear peaks were identified in anomalous difference Patterson maps corresponding to Yb 3+ replacing the Ca 2+ ions in the EF-hand motifs. The programs SOLVE/RE-SOLVE (Terwilliger, 2003) were used to determine and improve the experimental phases. The resulting electron density map was readily interpretable despite the modest resolution of the data set. Data collection and phasing statistics are summarized in Table 1 . Model building was performed using the program O (Jones, 1978) and refined against the native 2.0 Å resolution data set using CNS (Brü nger et al., 1998 ). Final refinement statistics are shown in Table 1 .
Expression, Purification, and In Vitro Acylation of GCAP1 Yeast N-myristoyltransferase (NMT1) and tobacco etch virus protease (TEV), both amino-terminally His tagged, were overexpressed in BL21(DE3) Escherichia coli (Invitrogen) from pRSET-yNMT1 and pRK793 (Addgene) (Kapust et al., 2001 ) plasmids, respectively. Proteins were purified using TALON resin (Clontech). Recombinant GCAP1 was overexpressed in High Five insect cells infected with baculovirus generated using the Bac-to-Bac system (Invitrogen) from plasmid pFB-GCAP1-1D4, which was derived from pFastBacHT (Invitrogen) and a GCAP1 cDNA clone using standard PCR-based cloning techniques. The sequence of the GCAP1 expressed is as follows: MSYYHHHHHHDYDIPTTENLYFQ/GNIMEGK.LAAEAAGTETSQVAPA, where the underlined residues are the initiation Met, 63His tag, TEV cleavage site, and 1D4 tag, respectively. The TEV excision site is indicated by a slash and the GCAP1 sequence is italicized. TALON resin (Clontech) was used to purify GCAP1 from cleared insect cell lysate obtained by sonication and ultracentrifugation. The protein, eluted in 200 mM imidazole (pH 7.0), 50 mM monosodium phosphate, 300 mM NaCl, and 5% glycerol, was diluted 2-fold with 50 mM HEPES (pH 7.5) and 5% glycerol and treated with TEV to remove the His tag. Amino-terminal acylation with 16-NBD-palmitoyl-CoA (Avanti Lipids) was carried out at 30 C for 12 hr in a reaction mixture (1 ml) containing 34 mM GCAP1 in diluted imidazole elution buffer, 50 mM HEPES (pH 8.0), 0.46 mM NMT, and 200 mM 16-NBD-palmitoyl-CoA. Acylated-GCAP1 was purified by immunoaffinity chromatography on monoclonal antibody 1D4 Sepharose 4B. The column was equilibrated and washed (30 bed volumes) with 10 mM HEPES (pH 7.4) and the protein was eluted with 50 mM HEPES (pH 7.4), 250 mM KCl, 50 mM NaCl, and 2 mg/ml 1D4 peptide. GCAP1 acylation was essentially complete. Nonacylated protein was undetectable by SDS-PAGE and only N-terminal acylation was observed by mass spectrometry (data not shown).
Fluorescence Spectroscopy and Cesium Quenching Steady-state fluorescence emission spectra were obtained between 480 and 600 nm with an excitation wavelength of 460 nm at 20 C. Fluorescence values were corrected for dilution effects and background emission of the buffer. Cesium chloride at a concentration range of 0.005-0.2 M was used as a quencher to determine the accessibility of the emissive 16-NBD-palmitoyl group covalently bound to the N terminus of GCAP1. The Ca 2+ -free sample mixture contained 0.2 mM 16-NBD-palmitoyl-GCAP1 in buffer composed of 40 mM HEPES (pH 7.4), 48 mM KCl, 8 mM NaCl, 10 mM MgCl 2 , and 1.4 mM EGTA. For measurements at high Ca 2+ concentrations, the sample mix was supplemented with 2 mM Ca 2+ , of which 0.6 mM remained unbound to EGTA. A solution of 0.2 mM 16-NBD-palmitoyl-CoA was used to obtain the data for free probe.
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